Joseph P. Pellegrino JR - Dec 2, 2023 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
Chief Financial Officer, Director
Signature
/s/ David C. Hissong
Stock symbol
LMAT
Transactions as of
Dec 2, 2023
Transactions value $
-$5,598
Form type
4
Date filed
12/5/2023, 04:10 PM
Previous filing
Dec 4, 2023
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $0 +8 +0.1% $0.00 7.77K Dec 2, 2023 Direct F1
transaction LMAT Common Stock Tax liability -$5.6K -104 -1.34% $53.83 7.67K Dec 2, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Options Exercise $0 -8 -26.74% $0.00 21.9 Dec 2, 2023 Common Stock 8 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2 These shares represent shares withheld by the Issuer to satisfy tax withholding obligations incurred upon the vesting of restricted stock units awarded to the reporting person on December 2, 2020. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934.
F3 These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.